6712.TWO Ever Supreme Bio Technology Co. Ltd

Healthcare Biotechnology Taiwan OTC Exchange
144.50 TWD
Close of Nov 5, 2026
120.95 184.00
Market cap
TWD 14.5B
P/E
29.4x
P/B
5.23x
ROE
15.8%
Dividend yield
2.81%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 6712.TWO undervalued?

Graham number
Price144.50
Graham value55.24
Premium161.6%

6712.TWO trades 161.6% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Ever Supreme Bio Technology Co. Ltd fundamental analysis

No fundamental analysis for Ever Supreme Bio Technology Co. Ltd yet.

Ever Supreme Bio Technology Co. Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Ever Supreme Bio Technology Co. Ltd

Ever Supreme Bio Technology Co., Ltd engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells in Taiwan. The company operates through two segments: Cell Preparation Business and Other Operating Business segments. The company's products include umbilical cord mesenchymal stem cells, a drug candidate in Phase I clinical trials for the treatment of myocardial infarction and stroke. It also develops dendritic…

Full company profile